Suramin for prostatic cancer: a phase I/II study in advanced extensively pretreated disease. 1990

A T Van Oosterom, and E A De Smedt, and L J Denis, and E A de Bruijn, and C Mahler
Department of Oncology, Antwerp University Hospital, Edegem, Belgium.

UI MeSH Term Description Entries
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D008297 Male Males
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D012074 Remission Induction Therapeutic act or process that initiates a response to a complete or partial remission level. Induction of Remission,Induction, Remission,Inductions, Remission,Remission Inductions
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013498 Suramin A polyanionic compound with an unknown mechanism of action. It is used parenterally in the treatment of African trypanosomiasis and it has been used clinically with diethylcarbamazine to kill the adult Onchocerca. (From AMA Drug Evaluations Annual, 1992, p1643) It has also been shown to have potent antineoplastic properties. Germanin,Moranil,Naganin,Naganol,Naphuride,Suramin Sodium,Suramin, Hexasodium Salt,Suramin, Monosodium Salt,Hexasodium Salt Suramin,Monosodium Salt Suramin,Salt Suramin, Hexasodium,Salt Suramin, Monosodium,Sodium, Suramin

Related Publications

A T Van Oosterom, and E A De Smedt, and L J Denis, and E A de Bruijn, and C Mahler
October 1984, American journal of clinical oncology,
A T Van Oosterom, and E A De Smedt, and L J Denis, and E A de Bruijn, and C Mahler
January 1993, European journal of cancer (Oxford, England : 1990),
A T Van Oosterom, and E A De Smedt, and L J Denis, and E A de Bruijn, and C Mahler
April 1985, British journal of urology,
A T Van Oosterom, and E A De Smedt, and L J Denis, and E A de Bruijn, and C Mahler
January 1998, Tumori,
A T Van Oosterom, and E A De Smedt, and L J Denis, and E A de Bruijn, and C Mahler
April 1998, Anti-cancer drugs,
A T Van Oosterom, and E A De Smedt, and L J Denis, and E A de Bruijn, and C Mahler
January 1995, Cancer,
A T Van Oosterom, and E A De Smedt, and L J Denis, and E A de Bruijn, and C Mahler
September 2004, Cancer chemotherapy and pharmacology,
A T Van Oosterom, and E A De Smedt, and L J Denis, and E A de Bruijn, and C Mahler
May 2006, Oncology reports,
A T Van Oosterom, and E A De Smedt, and L J Denis, and E A de Bruijn, and C Mahler
September 2022, Cancer discovery,
A T Van Oosterom, and E A De Smedt, and L J Denis, and E A de Bruijn, and C Mahler
January 2000, Cancer chemotherapy and pharmacology,
Copied contents to your clipboard!